ArticlePharmaceutics2025

In Vivo Iterative Adjuvant Screening Identifies an Intranasal Vaccine Formulation for Elicitation of Protective Mucosal Immune Responses Against SARS-CoV-2.

Yang Jiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.